Analysts cut hundreds of millions from Tilray, Canopy, Aurora marijuana sales forecasts

Analysts have slashed hundreds of millions of dollars off their 2022 sales forecasts for three Canadian cannabis producers, reflecting an increasingly competitive landscape across the adult-use industry, falling overall prices and poor execution by some executive teams.

Canadian marijuana company Tilray acquires Colorado distillery for $102.9M

Canadian marijuana producer Tilray has taken another step into the U.S. alcohol industry by acquiring Colorado-based Breckenridge Distillery for an undisclosed sum, with plans to launch cannabis-infused whiskey.

Marijuana firm Tilray’s executive pay gets cool reception from shareholders

Shareholders approved Tilray’s executive compensation scheme in a nonbinding vote at the marijuana company’s annual general meeting Tuesday, but the results fell short of an overwhelming endorsement.

Tilray’s share of Canadian cannabis market plummets, but Auxly shines, data shows

Canadian cannabis producer Tilray has seen around one-third of its market share in Canada evaporate since it merged with Aphria in May, new data suggests, while rival Auxly Cannabis Group has more than doubled its position over the same period.

Tilray latest Canadian firm to strike cannabis supply deal in Luxembourg

Tilray reached a deal with Luxembourg’s Ministry of Health to supply the small European country with medical cannabis, the company announced Tuesday, becoming the third Canadian cannabis producer since 2019 to supply the burgeoning market.

Tilray CEO open to M&A in Canada as cannabis revenue misses target

Canadian cannabis producer Tilray reported net revenue of $168 million (210 million Canadian dollars) for the June-August quarter, the first full quarter of sales after the merger between Aphria and Tilray closed earlier this year.

Cannabis producer Tilray shutting ‘flagship’ facility in Nanaimo

Marijuana producer Tilray Inc. is shutting down a “‘flagship” facility in Nanaimo, British Columbia, as part of the company’s plan to save money following its merger with Aphria, the company confirmed in an email to MJBizDaily.

How Tilray-MedMen deal could impact either cannabis company’s US aspirations

Last week, British Columbia-based Tilray (TLRY on Nasdaq, TSX), the second-largest Canadian licensed producer by market cap, announced a transaction to gain a substantial interest in U.S. cannabis retailer MedMen.